Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to Pneumococcal Vaccination in Post-CAP Patients
NCT02141009Phase 4Completed
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in Pneumococcal pneumonia (PP). Started Apr 2014; status: completed.
02
Drugs
Prevnar 13
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT02141009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141009.